Key Highlights
- CEO Michael Intrator offloaded 77,939 shares at $74.05 per share, generating $5.77M and reducing his holdings by 1.34%
- CSO Brian Venturo disposed of 65,005 shares at the identical $74.05 price point for $4.81M in proceeds on March 31
- The AI infrastructure provider secured an oversubscribed $8.5 billion credit facility backed by GPU assets
- Fourth quarter revenue reached $1.57B, representing a 110% year-over-year increase, though earnings per share of -$0.89 fell short of forecasts by $0.28
- Wall Street maintains a “Moderate Buy” consensus rating with analysts targeting $121.06 on average
Top executives at CoreWeave executed significant stock disposals on the same trading day — yet the AI infrastructure company’s massive GPU-backed financing arrangement continues to fuel investor optimism.
CoreWeave, Inc. Class A Common Stock, CRWV
Chief Executive Officer Michael Intrator divested 77,939 Class A common shares at a price of $74.05 apiece on March 31, realizing proceeds of $5.77 million. This transaction trimmed his ownership position by 1.34%, leaving the CEO holding 5,728,900 shares valued at approximately $424 million based on current market prices.
On that same trading session, Chief Strategy Officer Brian Venturo executed a sale of 65,005 shares at the matching $74.05 price point, collecting $4.81 million. Venturo simultaneously exercised stock options, acquiring 126,752 shares through restricted stock unit conversions during the identical timeframe. Securities and Exchange Commission filings documented both executive transactions.
The dual sell-off resulted in more than $10.5 million in total stock disposals within a single trading day.
Massive $8.5 Billion Credit Facility Dominates Headlines
The executive stock sales occurred in parallel with a significantly larger corporate development: CoreWeave finalized an $8.5 billion delayed draw term loan arrangement — marking its fourth such financing vehicle — collateralized by graphics processing units and client agreements. The heavily oversubscribed transaction attracted participation from international banking institutions, asset management firms, and insurance company investors.
Evercore ISI reaffirmed its Outperform recommendation alongside a $120 price objective in response to the announcement. Citizens maintained its Market Outperform designation with an $180 target price. Stifel preserved its neutral position at $110, observing that the facility reduces CoreWeave’s weighted average cost of capital.
The financing proceeds are designated for artificial intelligence infrastructure and data center expansion initiatives, with market analysts broadly identifying it as the primary driver behind the stock’s recent multi-percentage-point appreciation.
Revenue Explosion Contrasts With Profit Shortfall
CoreWeave’s latest quarterly financial performance presented a contrasting narrative. Top-line revenue registered at $1.57 billion, reflecting a 110% year-over-year expansion — an exceptional growth trajectory by industry standards.
However, profitability metrics disappointed. Earnings per share landed at -$0.89, underperforming the analyst consensus expectation of -$0.61 by $0.28. The enterprise maintains a debt-to-equity ratio of 4.46 alongside a negative net margin of 22.75%.
On the technology front, CoreWeave achieved benchmark-leading performance in the MLPerf Inference v6.0 evaluation suite utilizing Nvidia GB200 and GB300 infrastructure. Its GB300 NVL72 configuration delivered double the performance scores compared to the preceding MLPerf 5.1 testing cycle.
In separate developments, Barclays preserved an Equalweight rating with a $90 price objective, citing reports of a partnership modification involving a Texas-based data center initiative. Industry sources indicate Poolside is pursuing alternative partners following the dissolution of arrangements with CoreWeave.
Bank of America recently elevated CRWV from Neutral to Buy, establishing a $100 valuation target. Goldman Sachs retains a Neutral stance with an $86 objective. Analyst coverage breaks down to nineteen Buy ratings, eleven Hold recommendations, and two Sell opinions.
The Wall Street consensus price target registers at $121.06 versus the current trading price of $82.24, with shares fluctuating between $33.51 and $187.00 over the trailing 52-week period.


